Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy
Tools
Tools
Tools
Bruusgaard-Mouritsen, M.A., Koo, G., Heinrichsen, A.S., Melchiors, B.B., Krantz, M.S., Plager, J.H., Boxer, M., Phillips, E.J., Stone, C.A. and Garvey, L.H. (2022) Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. The Journal of Allergy and Clinical Immunology: In Practice, 10 (3). P859-862.
![[img]](https://researchrepository.murdoch.edu.au/style/images/fileicons/application_pdf.png)
PDF
- Authors' Version
Embargoed until January 2023.
Embargoed until January 2023.
Link to Published Version: https://doi.org/10.1016/j.jaip.2021.12.025
*Subscription may be required
*Subscription may be required
Abstract
Polyethylene glycols (PEGs) and the structurally related polysorbates (PEG sorbitans—PEG molecular weight, 880-1056 g/mol) are excipients commonly used in small-molecule pharmaceutical drugs, as well as in some vaccines and most mAbs...
| Item Type: | Journal Article |
|---|---|
| Murdoch Affiliation(s): | Institute for Immunology and Infectious Diseases |
| Publisher: | Elsevier Inc. |
| Copyright: | © 2021 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology |
| URI: | http://researchrepository.murdoch.edu.au/id/eprint/63435 |
 |
Item Control Page |